SCHEMBL2610455

SCHEMBL2610455

CC(=O)OC[C@@H]1C[C@]1(c1cccc(F)c1)C(C)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.41
SLC6A4 P31645 2/20 0.41
CCR2 P41597 1/20 0.40
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP2C19 P33261 1/20 0.38
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA4 P43681 2/20 0.37
SLC6A3 Q01959 2/20 0.37
HSD11B1 P28845 1/20 0.37
CHRNA1 P02708 1/20 0.37
CHRNB1 P11230 1/20 0.37
KDM1A O60341 2/20 0.37
HCRTR2 O43614 5/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2610458 0.92 SLC6A2 (0.41) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL2610457 0.81 HTR2A (0.43) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL2118783 0.78 SLC6A4 (0.42) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL22666390 0.78 SLC6A4 (0.42) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL22666434 0.78 SLC6A4 (0.42) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL16406055 0.78 SLC6A4 (0.45) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL15177888 0.78 SLC6A4 (0.42) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL2610470 0.75 CCR2 (0.36) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL19645410 0.73 SLC6A2 (0.38) SLC6A2SLC6A4CCR2HTR2AHTR2C
SCHEMBL22666391 0.71 HCRTR2 (0.36) SLC6A2SLC6A4CCR2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8268848-B2 Cyclopropane compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-09-18 US disclosed
US-20120095031-A1 CYCLOPROPANE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095031-A1 CYCLOPROPANE COMPOUND HCRTR1, HCRTR2, CNR1 SLC6A2 331/4885SLC6A4 370/4885CCR2 267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.